MicroRNA-212 negatively regulates starvation induced autophagy in prostate cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis and cellular senescence

Oncotarget

Volumn 6, Issue 33, 2015, Pages 34446-34457

  Ramalinga, Malathi ^a   Roy, Arpita ^a   Srivastava, Anvesha ^a   Bhattarai, Asmita ^a   Harish, Varsha ^b   Suy, Simeng ^c   Collins, Sean ^c   Kumar, Deepak ^a,c  

^a UNIVERSITY OF THE DISTRICT OF COLUMBIA   (United States)

^b Groton School   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

Autophagy; MicroRNA; MiR 212; Prostate cancer; SIRT1

Indexed keywords

MICRORNA; MICRORNA 212 3P; SIRTUIN 1; UNCLASSIFIED DRUG; MIRN212 MICRORNA, HUMAN; SIRT1 PROTEIN, HUMAN; SMALL INTERFERING RNA; TUMOR MARKER;

ARTICLE; AUTOPHAGY; CELL AGING; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENZYME INHIBITION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PROSTATE CANCER; PROSTATE CANCER CELL LINE; PROTEIN EXPRESSION; SENESCENCE; TUMOR VASCULARIZATION; UMBILICAL VEIN ENDOTHELIAL CELL; AREA UNDER THE CURVE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; LASER CAPTURE MICRODISSECTION; MALE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; RECEIVER OPERATING CHARACTERISTIC; TUMOR CELL LINE; WESTERN BLOTTING;

AREA UNDER CURVE; AUTOPHAGY; BIOMARKERS, TUMOR; BLOTTING, WESTERN; CELL AGING; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LASER CAPTURE MICRODISSECTION; MALE; MICRORNAS; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; RNA, SMALL INTERFERING; ROC CURVE; SIRTUIN 1; TRANSFECTION;

EID: 84946615576     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.5920     Document Type: Article

References (49)

1. Siegel R, Ma J, Zou Z and Jemal A. Cancer statistics, 2014. CA: a cancer journal for clinicians. 2014; 64:9-29.
2. Siegel RL, Miller KD and Jemal A. Cancer statistics, 2015. CA: a cancer journal for clinicians. 2015; 65:5-29.
3. Hanahan D and Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144:646-674.
4. Lin Z and Fang D. The Roles of SIRT1 in Cancer. Genes Cancer. 2013; 4:97-104.
5. Roth M and Chen WY. Sorting out functions of sirtuins in cancer. Oncogene. 2014; 33:1609-1620.
6. Potente M, Ghaeni L, Baldessari D, Mostoslavsky R, Rossig L, Dequiedt F, Haendeler J, Mione M, Dejana E, Alt FW, Zeiher AM and Dimmeler S. SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev. 2007; 21:2644-2658.
7. Guo JY, Xia B and White E. Autophagy-mediated tumor promotion. Cell. 2013; 155:1216-1219.
8. Wei Y, Zou Z, Becker N, Anderson M, Sumpter R, Xiao G, Kinch L, Koduru P, Christudass CS, Veltri RW, Grishin NV, Peyton M, Minna J, Bhagat G and Levine B. EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance. Cell. 2013; 154:1269-1284.
9. Galluzzi L, Pietrocola F, Levine B and Kroemer G. Metabolic control of autophagy. Cell. 2014; 159:1263-1276.
10. Levine B and Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008; 132:27-42.
11. Powell MJ, Casimiro MC, Cordon-Cardo C, He X, Yeow WS, Wang C, McCue PA, McBurney MW and Pestell RG. Disruption of a Sirt1-dependent autophagy checkpoint in the prostate results in prostatic intraepithelial neoplasia lesion formation. Cancer Res. 2011; 71:964-975.
12. Lee IH, Cao L, Mostoslavsky R, Lombard DB, Liu J, Bruns NE, Tsokos M, Alt FW and Finkel T. A role for the NADdependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci U S A. 2008; 105:3374-3379.
13. Ambros V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell. 2003; 113:673-676.
14. Yates LA, Norbury CJ and Gilbert RJ. The long and short of microRNA. Cell. 2013; 153:516-519.
15. Srivastava A, Goldberger H, Dimtchev A, Marian C, Soldin O, Li X, Collins SP, Suy S and Kumar D. Circulatory miR-628-5p is downregulated in prostate cancer patients. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014; 35:4867-4873.
16. Srivastava A, Goldberger H, Afzal Z, Suy S, Collins SP and Kumar D. Detection of circulatory microRNAs in prostate cancer. Methods in molecular biology. 2015; 1238:523-538.
17. Walter BA, Valera VA, Pinto PA and Merino MJ. Comprehensive microRNA Profiling of Prostate Cancer. Journal of Cancer. 2013; 4:350-357.
18. Srivastava A, Goldberger H, Dimtchev A, Ramalinga M, Chijioke J, Marian C, Oermann EK, Uhm S, Kim JS, Chen LN, Li X, Berry DL, Kallakury BV, Chauhan SC, Collins SP, Suy S, et al. MicroRNA profiling in prostate cancer-the diagnostic potential of urinary miR-205 and miR-214. PloS one. 2013; 8:e76994.
19. Yang MM, Fan XJ, Du WT, Ren PL and Liu J. [Research on regulation of cell senescence by miRNA-34a]. Sichuan da xue xue bao Yi xue ban = Journal of Sichuan University Medical science edition. 2013; 44:1-5.
20. Overhoff MG, Garbe JC, Koh J, Stampfer MR, Beach DH and Bishop CL. Cellular senescence mediated by p16INK4A-coupled miRNA pathways. Nucleic acids research. 2014; 42:1606-1618.
21. Wada R, Akiyama Y, Hashimoto Y, Fukamachi H and Yuasa Y. miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer. International journal of cancer Journal international du cancer. 2010; 127:1106-1114.
22. Hatakeyama H, Cheng H, Wirth P, Counsell A, Marcrom SR, Wood CB, Pohlmann PR, Gilbert J, Murphy B, Yarbrough WG, Wheeler DL, Harari PM, Guo Y, Shyr Y, Slebos RJ and Chung CH. Regulation of heparinbinding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinoma. PloS one. 2010; 5:e12702.
23. Scapoli L, Palmieri A, Lo Muzio L, Pezzetti F, Rubini C, Girardi A, Farinella F, Mazzotta M and Carinci F. MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression. International journal of immunopathology and pharmacology. 2010; 23:1229-1234.
24. Park JK, Henry JC, Jiang J, Esau C, Gusev Y, Lerner MR, Postier RG, Brackett DJ and Schmittgen TD. miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor. Biochemical and biophysical research communications. 2011; 406:518-523.
25. Ucar A, Vafaizadeh V, Jarry H, Fiedler J, Klemmt PA, Thum T, Groner B and Chowdhury K. miR-212 and miR-132 are required for epithelial stromal interactions necessary for mouse mammary gland development. Nature genetics. 2010; 42:1101-1108.
26. Wayman GA, Davare M, Ando H, Fortin D, Varlamova O, Cheng HY, Marks D, Obrietan K, Soderling TR, Goodman RH and Impey S. An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP. Proc Natl Acad Sci U S A. 2008; 105:9093-9098.
27. Borrego-Diaz E, Powers BC, Azizov V, Lovell S, Reyes R, Chapman B, Tawfik O, McGregor D, Diaz FJ, Wang X and Veldhuizen PV. A potential regulatory loop between Lin28B:miR212 in androgen-independent prostate cancer. International journal of oncology. 2014; 45:2421-2429.
28. Zhao JL, Zhang L, Guo X, Wang JH, Zhou W, Liu M, Li X and Tang H. miR-212/132 downregulates SMAD2 expression to suppress the G1/S phase transition of the cell cycle and the epithelial to mesenchymal transition in cervical cancer cells. IUBMB life. 2015; 67:380-394.
29. Dou C, Wang Y, Li C, Liu Z, Jia Y, Li Q, Yang W, Yao Y, Liu Q and Tu K. MicroRNA-212 suppresses tumor growth of human hepatocellular carcinoma by targeting FOXA1. Oncotarget. 2015.
30. Liu H, Li C, Shen C, Yin F, Wang K, Liu Y, Zheng B, Zhang W, Hou X, Chen X, Wu J, Wang X, Zhong C, Zhang J, Shi H, Ai J, et al. MiR-212-3p inhibits glioblastoma cell proliferation by targeting SGK3. Journal of neuro-oncology. 2015; 122:431-439.
31. Jung-Hynes B and Ahmad N. Role of p53 in the antiproliferative effects of Sirt1 inhibition in prostate cancer cells. Cell cycle. 2009; 8:1478-1483.
32. Jiang X, Chen X, Chen L, Ma Y, Zhou L, Qi Q, Liu Y, Zhang S, Luo J and Zhou X. Upregulation of the miR-212/132 cluster suppresses proliferation of human lung cancer cells. Oncology reports. 2015; 33:705-712.
33. Kim SY, Ko YS, Park J, Choi Y, Park JW, Kim Y, Pyo JS, Yoo YB, Lee JS and Lee BL. Forkhead Transcription Factor FOXO1 Inhibits Angiogenesis in Gastric Cancer in Relation to SIRT1. Cancer research and treatment: official journal of Korean Cancer Association. 2015.
34. Maizel J, Xavier S, Chen J, Lin CH, Vasko R and Goligorsky MS. Sirtuin 1 ablation in endothelial cells is associated with impaired angiogenesis and diastolic dysfunction. American journal of physiology Heart and circulatory physiology. 2014; 307:H1691-1704.
35. Miyashita H, Watanabe T, Hayashi H, Suzuki Y, Nakamura T, Ito S, Ono M, Hoshikawa Y, Okada Y, Kondo T and Sato Y. Angiogenesis inhibitor vasohibin-1 enhances stress resistance of endothelial cells via induction of SOD2 and SIRT1. PloS one. 2012; 7:e46459.
36. Zhao T, Li J and Chen AF. MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. American journal of physiology Endocrinology and metabolism. 2010; 299:E110-116.
37. Kroh EM, Parkin RK, Mitchell PS and Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods. 2010; 50:298-301.
38. Kumarswamy R, Volkmann I, Beermann J, Napp LC, Jabs O, Bhayadia R, Melk A, Ucar A, Chowdhury K, Lorenzen JM, Gupta SK, Batkai S and Thum T. Vascular importance of the miR-212/132 cluster. European heart journal. 2014; 35:3224-3231.
39. Zhang L, Huang D, Wang Q, Shen D, Wang Y, Chen B, Zhang J and Gai L. MiR-132 inhibits expression of SIRT1 and induces pro-inflammatory processes of vascular endothelial inflammation through blockade of the SREBP-1c metabolic pathway. Cardiovascular drugs and therapy/sponsored by the International Society of Cardiovascular Pharmacotherapy. 2014; 28:303-311.
40. Ucar A, Gupta SK, Fiedler J, Erikci E, Kardasinski M, Batkai S, Dangwal S, Kumarswamy R, Bang C, Holzmann A, Remke J, Caprio M, Jentzsch C, Engelhardt S, Geisendorf S, Glas C, et al. The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nature communications. 2012; 3:1078.
41. Green DR and Levine B. To be or not to be? How selective autophagy and cell death govern cell fate. Cell. 2014; 157:65-75.
42. Gomez-Cabello D, Adrados I, Gamarra D, Kobayashi H, Takatsu Y, Takatsu K, Gil J and Palmero I. DGCR8-mediated disruption of miRNA biogenesis induces cellular senescence in primary fibroblasts. Aging cell. 2013; 12:923-931.
43. Schraml E and Grillari J. From cellular senescence to ageassociated diseases: the miRNA connection. Longevity & healthspan. 2012; 1:10.
44. Cichowski K and Hahn WC. Unexpected pieces to the senescence puzzle. Cell. 2008; 133:958-961.
45. Collado M, Blasco MA and Serrano M. Cellular senescence in cancer and aging. Cell. 2007; 130:223-233.
46. Hayakawa T, Iwai M, Aoki S, Takimoto K, Maruyama M, Maruyama W and Motoyama N. SIRT1 suppresses the senescence-associated secretory phenotype through epigenetic gene regulation. PloS one. 2015; 10:e0116480.
47. Tran D, Bergholz J, Zhang H, He H, Wang Y, Zhang Y, Li Q, Kirkland JL and Xiao ZX. Insulin-like growth factor-1 regulates the SIRT1-p53 pathway in cellular senescence. Aging cell. 2014; 13:669-678.
48. Ohanna M, Bonet C, Bille K, Allegra M, Davidson I, Bahadoran P, Lacour JP, Ballotti R and Bertolotto C. SIRT1 promotes proliferation and inhibits the senescencelike phenotype in human melanoma cells. Oncotarget. 2014; 5:2085-2095.
49. Roy A, Zhang M, Saad Y and Kolattukudy PE. Antidicer RNAse activity of monocyte chemotactic protein-induced protein-1 is critical for inducing angiogenesis. American journal of physiology Cell physiology. 2013; 305:C1021-1032